Skip to main content

Table 2 The association between PUFA's dietary intake and the odds of asthma in children

From: The association of polyunsaturated fatty acids and asthma: a cross-sectional study

Variables

Model 1

Model 2

OR (95% CI)

P

OR (95% CI)

P

Total PUFAs (gm)

1.00 (0.99–1.01)

0.377

1.00 (0.99–1.01)

0.950

Total n − 3 PUFAs

0.73 (0.51–1.04)

0.084

0.63 (0.43–0.91)

0.016

 Octadecatrienoic acid (gm)

0.93 (0.84–1.04)

0.235

0.87 (0.75–1.01)

0.079

 Octadecatetraenoic acid (gm)

8.35 (0.92–75.60)

0.061

4.54 (0.45–45.94)

0.203

 Eicosapentaenoic acid (gm)

0.46 (0.18–1.21)

0.119

0.35 (0.13–0.95)

0.042

 Docosapentaenoic acid (gm)

3.39 (0.27–41.93)

0.343

0.66 (0.04–9.81)

0.761

 Docosahexaenoic acid (gm)

0.46 (0.23–0.90)

0.026

0.37 (0.19–0.74)

0.006

Total n − 6 PUFAs

1.00 (0.99–1.01)

0.405

1.00 (0.90–1.10)

0.920

 Octadecadienoic acid (gm)

1.01 (0.99–1.02)

0.327

1.05 (0.97–1.14)

0.255

 Eicosatetraenoic acid (gm)

1.73 (0.93–3.23)

0.087

1.08 (0.56–2.09)

0.820

Total n − 3/total n − 6

0.06 (0.00–6.49)

0.241

0.02 (0.00–4.33)

0.161

  1. OR, odds ratio; CI, confidence interval; polyunsaturated fatty acids, PUFAs;
  2. Model 1 adjusted for energy;
  3. Model 2 adjusted for energy, total fat, maternal smoking during pregnancy, weight at birth, age, BMI, race, gender, and family PIR